Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
Tesla faces scrutiny over cancellation of its planned affordable 'Model 2' electric vehicle, as Musk's denial of the project's demise raises concerns about misleading investors and SEC compliance.
Microsoft announces major layoffs, citing organizational changes to improve efficiency and competitiveness, as tech sector streamlines operations and shifts focus toward AI-driven roles.
Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
Tesla faces scrutiny over cancellation of its planned affordable 'Model 2' electric vehicle, as Musk's denial of the project's demise raises concerns about misleading investors and SEC compliance.
Microsoft announces major layoffs, citing organizational changes to improve efficiency and competitiveness, as tech sector streamlines operations and shifts focus toward AI-driven roles.